Benzohydroxamic acids as potent and selective anti-HCV agents

Area of Science:

• Medicinal Chemistry
• Virology
• Drug Discovery

Background:

• Hepatitis C virus (HCV) poses a significant global health challenge, necessitating novel antiviral strategies.
• Existing treatments face challenges, driving research into new compound classes with unique mechanisms of action.

Purpose of the Study:

• To synthesize and evaluate a diverse library of benzohydroxamic acid (BHA) derivatives for anti-HCV activity.
• To elucidate the mechanism of action for potent BHA compounds against HCV replication.

Main Methods:

• Synthesis of 40 diverse BHA derivatives.
• HCV full-genome replicon assay to assess antiviral activity.
• In vitro assays against key viral enzymes (NS3, NS5B).
• Assessment of activity against poliomyelitis virus (PV) to determine specificity.

Main Results:

• Several BHA derivatives exhibited potent antiviral activity, suppressing HCV replication at sub-micromolar concentrations.
• Compounds were inactive against NS3 and NS5B viral enzymes, suggesting host cell targets.
• Antiviral activity correlated with metal coordination by the BHA hydroxamic group.
• BHAs demonstrated specific activity against HCV, showing no inhibition of PV propagation.

Conclusions:

• Benzohydroxamic acids represent a promising class of antiviral agents against HCV.
• The mechanism likely involves targeting host cell factors essential for viral replication.
• Further investigation into BHA-host interactions could lead to novel HCV therapeutics.